Sales Forecasting for Pharmaceuticals
An evidence-based approach
By Gary Johnson
Pharmaceutical Executive Training Courses
Executive training courses for the pharmaceutical industry
Pharma industry’s leading executive training courses
Inpharmation provides the industry’s leading forecasting, pricing and market access pharmaceutical training courses. By attending one of our courses you will gain insight to the following:
- The timeless principles of forecasting: enduring principles that hold constant even in today’s fast changing environment. Learn from Inpharmation’s decades of experience in providing strategic recommendations to the pharmaceutical industry.
-
Pharma-Specific™ forecasting methodologies and techniques: forecasting agencies frequently use techniques that are inappropriate for the pharmaceutical forecasts. Make sure you know which forecasting approaches to use for your specific business questions.
- Forecasting approaches specific for your situation: forecasting approaches need to be tailored to your specific situations. Make sure you know which approaches should be used for your brand life-cycle stage, launch countries and therapeutic area.
Click here for more information on CEL executive training courses for forecasting
Click here for more information on CEL executive training courses for pricing and market access
What can evidence-based insights do for you?
Inpharmation champions an evidence-based approach to forecasting for the pharmaceutical industry. By attending this training course you’ll receive a focussed overview of the forecast approaches, models and methodologies that have been proven to work for the pharmaceutical industry. Don’t just take our word for it; Inpharmation are highly rated by 93% of course attendees.
Course participants receive a free course-specific copy of the industry-leading forecasting text by Gary Johnson. A number of the world’s leading pharma companies batch order Gary Johnson’s books to help instil an evidence-based approach to forecasting in their organizations.
To book, please visit www.celforpharma.com.
Please send me a free brochure outlining the full syllabus of the course.
We have approaches for each stage of your pharmaceutical product’s lifecycle. Behavior-based pricing and econometric pricing models for early stage assets, Payer summit, Payer conjoint and probabilistic van Westendorp for products coming to market.
We also offer international system models and price-demand elasticity models for products near or past launch.
Running Europe’s leading pharmaceutical pricing for market access executive training courses, we place great importance on transferring knowledge and skills to our clients.
OUR BOOKS:
Value Pricing for Market Access
Evidence-based pricing for pharmaceuticals
By Gary Johnson
Pharma-Specific Conjoint
Evidence-based conjoint analysis for an evidence-based industry
By Gary Johnson